Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
15 p, 2.0 MB Monitoring t-cell responses in translational studies: optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-specific responses / Brinke, Anja ten (Sanquin Research (Amsterdam)) ; Marek-Trzonkowska,Natalia (Medical University of Gdansk. Department of Family Medicine) ; Mansilla López, María José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Turksma, Annelies W. (Sanquin Research (Amsterdam)) ; Piekarska, Karolina (Medical University of Gdansk. Department of Family Medicine) ; Iwaszkiewicz-Grzes, Dorota (Medical University of Gdansk. Department of Clinical Immunology and Transplantology) ; Passerini, Laura (IRCCS San Raffaele Scientific Institute) ; Locafaro, Grazia (IRCCS San Raffaele Scientific Institute) ; Puñet Ortiz, Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; van Ham, S. Marieke (Sanquin Research (Amsterdam)) ; Hernandez Fuentes, Maria P. (MRC Centre for Transplantation, King's College London) ; Martínez Cáceres, Eva M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gregori, Silvia (IRCCS San Raffaele Scientific Institute) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Adoptive therapy with regulatory T cells or tolerance-inducing antigen (Ag)- presenting cells is innovative and promising therapeutic approach to control undesired and harmful activation of the immune system, as observed in autoimmune diseases, solid organ and bone marrow transplantation. [...]
2017
Frontiers in immunology, Vol. 8 (december 2017) , p. 1-15  
2.
14 p, 516.6 KB Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies / Lord, Phillip (Newcastle University. School of Computing Science) ; Spiering, Rachel (Newcastle University. Institute of Cellular Medicine) ; Aguillon, Juan C. (Universidad de Chile. Instituto de Ciencias Biomédicas (ICBM)) ; Anderson, Amy E. (Newcastle University. Institute of Cellular Medicine) ; Appel, Silke (University of Bergen. Broegelmann Research Laboratory) ; Benítez Ribas, Daniel (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)) ; Brinke, Anja ten (Sanquin Research (Amsterdam)) ; Broere, Femke (Utrecht University) ; Cools, Nathalie (University of Antwerp. Vaccine & Infectious Disease Institute) ; Cuturi, Maria Cristina (Center for Research in Transplantation and Immunology (Nantes, França)) ; Diboll, Julie (Newcastle University. Institute of Cellular Medicine) ; Geissler, Edward K. (University Hospital Regensburg. Department of Surgery) ; Giannoukakis, Nick (Institute of Cellular Therapeutics (Pittsburgh, Estats Units d'Amèrica)) ; Gregori, Silvia (San Raffaele Telethon Institute for Gene Therapy (Milà, Itàlia)) ; Ham, S. Marieke van (Sanquin Research (Amsterdam)) ; Lattimer, Staci (Newcastle University. School of Computing Science) ; Marshall, Lindsay (Newcastle University. School of Computing Science) ; Harry, Rachel A. (Newcastle University. Institute of Cellular Medicine) ; Hutchinson, James A. (University Hospital Regensburg. Department of Surgery) ; Isaacs, John D. (Newcastle University. Institute of Cellular Medicine) ; Joosten, Irma (Radboud University Medical Centre) ; Kooten, Cees van (Leiden University Medical Centre) ; López Díaz de Cerio, Ascensión (Clínica Universidad de Navarra) ; Nikolic, Tatjana (Leiden University Medical Centre) ; Oral, Haluk Barbaros (Uludag University. Faculty of Medicine) ; Sofronic Milosavljevic, Ljiljana (University of Belgrade. Institute for the Application of Nuclear Energy) ; Ritter, Thomas (National University of Ireland) ; Riquelme, Paloma (University Hospital Regensburg. Department of Surgery) ; Thomson, Angus W. (University of Pittsburgh School of Medicine) ; Trucco, Massimo (Institute of Cellular Therapeutics (Pittsburgh, Estats Units d'Amèrica)) ; Vives Pi, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hilkens, Catharien M. U. (Newcastle University. Institute of Cellular Medicine)
Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation. [...]
2016 - 10.7717/peerj.2300
PeerJ, Vol. 4 (August 2016) , p. e2300  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.